-
Consensus Rating
HoldBased on 28 Analyst Ratings
-
Consensus Price Target
$18.00300% Upside
Evoke Pharma, Inc. Frequently Asked Questions
-
What analysts cover Evoke Pharma, Inc.?
Evoke Pharma, Inc. has been rated by research analysts at Laidlaw in the past 90 days.